nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—Vismodegib—skin cancer	0.157	0.21	CbGbCtD
Clofazimine—CYP3A4—Temozolomide—skin cancer	0.136	0.182	CbGbCtD
Clofazimine—CYP3A4—Imiquimod—skin cancer	0.136	0.182	CbGbCtD
Clofazimine—CYP3A4—Vismodegib—skin cancer	0.0943	0.126	CbGbCtD
Clofazimine—ABCB1—Dactinomycin—skin cancer	0.0827	0.11	CbGbCtD
Clofazimine—CYP3A4—Vemurafenib—skin cancer	0.0746	0.0995	CbGbCtD
Clofazimine—ABCB1—Docetaxel—skin cancer	0.0427	0.057	CbGbCtD
Clofazimine—CYP3A4—Docetaxel—skin cancer	0.0256	0.0341	CbGbCtD
Clofazimine—Ichthyosis—Bleomycin—skin cancer	0.0196	0.0782	CcSEcCtD
Clofazimine—Ichthyosis acquired—Bleomycin—skin cancer	0.0196	0.0782	CcSEcCtD
Clofazimine—Phototoxicity—Imiquimod—skin cancer	0.0166	0.0662	CcSEcCtD
Clofazimine—Ichthyosis—Fluorouracil—skin cancer	0.0152	0.0608	CcSEcCtD
Clofazimine—Ichthyosis acquired—Fluorouracil—skin cancer	0.0152	0.0608	CcSEcCtD
Clofazimine—Suicide—Imiquimod—skin cancer	0.00612	0.0245	CcSEcCtD
Clofazimine—Completed suicide—Imiquimod—skin cancer	0.0054	0.0216	CcSEcCtD
Clofazimine—Abdominal pain upper—Vismodegib—skin cancer	0.004	0.016	CcSEcCtD
Clofazimine—Hypokalaemia—Vismodegib—skin cancer	0.00398	0.0159	CcSEcCtD
Clofazimine—Enteritis—Docetaxel—skin cancer	0.00371	0.0148	CcSEcCtD
Clofazimine—Weight decreased—Vismodegib—skin cancer	0.00342	0.0137	CcSEcCtD
Clofazimine—Bone pain—Imiquimod—skin cancer	0.00332	0.0132	CcSEcCtD
Clofazimine—Visual acuity reduced—Temozolomide—skin cancer	0.0032	0.0128	CcSEcCtD
Clofazimine—Hepatomegaly—Dactinomycin—skin cancer	0.00297	0.0119	CcSEcCtD
Clofazimine—Embolism—Temozolomide—skin cancer	0.00297	0.0118	CcSEcCtD
Clofazimine—Lymphadenopathy—Imiquimod—skin cancer	0.0027	0.0108	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00244	0.00976	CcSEcCtD
Clofazimine—Eosinophilia—Vemurafenib—skin cancer	0.00231	0.00924	CcSEcCtD
Clofazimine—Cystitis noninfective—Bleomycin—skin cancer	0.0022	0.00881	CcSEcCtD
Clofazimine—Cystitis—Bleomycin—skin cancer	0.00218	0.0087	CcSEcCtD
Clofazimine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00213	0.00852	CcSEcCtD
Clofazimine—Weight decreased—Vemurafenib—skin cancer	0.00211	0.00845	CcSEcCtD
Clofazimine—Bladder pain—Bleomycin—skin cancer	0.00204	0.00815	CcSEcCtD
Clofazimine—Embolism—Docetaxel—skin cancer	0.00197	0.00788	CcSEcCtD
Clofazimine—Decreased appetite—Vismodegib—skin cancer	0.00187	0.00747	CcSEcCtD
Clofazimine—Intestinal obstruction—Docetaxel—skin cancer	0.00186	0.00742	CcSEcCtD
Clofazimine—Fatigue—Vismodegib—skin cancer	0.00185	0.00741	CcSEcCtD
Clofazimine—Constipation—Vismodegib—skin cancer	0.00184	0.00735	CcSEcCtD
Clofazimine—Neuralgia—Docetaxel—skin cancer	0.00182	0.00728	CcSEcCtD
Clofazimine—Photosensitivity reaction—Imiquimod—skin cancer	0.00182	0.00727	CcSEcCtD
Clofazimine—Depression—Imiquimod—skin cancer	0.00177	0.00708	CcSEcCtD
Clofazimine—Asthenia—Vismodegib—skin cancer	0.00154	0.00616	CcSEcCtD
Clofazimine—Visual impairment—Imiquimod—skin cancer	0.00154	0.00614	CcSEcCtD
Clofazimine—Pruritus—Vismodegib—skin cancer	0.00152	0.00608	CcSEcCtD
Clofazimine—Diarrhoea—Vismodegib—skin cancer	0.00147	0.00588	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00146	0.00585	CcSEcCtD
Clofazimine—Vomiting—Vismodegib—skin cancer	0.00137	0.00546	CcSEcCtD
Clofazimine—Rash—Vismodegib—skin cancer	0.00136	0.00542	CcSEcCtD
Clofazimine—Dermatitis—Vismodegib—skin cancer	0.00136	0.00541	CcSEcCtD
Clofazimine—Bone pain—Docetaxel—skin cancer	0.00132	0.00528	CcSEcCtD
Clofazimine—Weight decreased—Bleomycin—skin cancer	0.00128	0.00512	CcSEcCtD
Clofazimine—Nausea—Vismodegib—skin cancer	0.00128	0.0051	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00127	0.00509	CcSEcCtD
Clofazimine—Hypokalaemia—Temozolomide—skin cancer	0.00126	0.00502	CcSEcCtD
Clofazimine—Decreased appetite—Vemurafenib—skin cancer	0.00116	0.00461	CcSEcCtD
Clofazimine—Fatigue—Vemurafenib—skin cancer	0.00115	0.00458	CcSEcCtD
Clofazimine—Constipation—Vemurafenib—skin cancer	0.00114	0.00454	CcSEcCtD
Clofazimine—Oedema—Imiquimod—skin cancer	0.00113	0.00453	CcSEcCtD
Clofazimine—Photosensitivity reaction—Temozolomide—skin cancer	0.00109	0.00435	CcSEcCtD
Clofazimine—Eosinophilia—Fluorouracil—skin cancer	0.00109	0.00435	CcSEcCtD
Clofazimine—Weight decreased—Temozolomide—skin cancer	0.00108	0.00432	CcSEcCtD
Clofazimine—Anorexia—Imiquimod—skin cancer	0.00108	0.00432	CcSEcCtD
Clofazimine—Hyperglycaemia—Temozolomide—skin cancer	0.00108	0.0043	CcSEcCtD
Clofazimine—Depression—Temozolomide—skin cancer	0.00106	0.00424	CcSEcCtD
Clofazimine—Hepatitis—Dactinomycin—skin cancer	0.00106	0.00422	CcSEcCtD
Clofazimine—Body temperature increased—Vemurafenib—skin cancer	0.00105	0.0042	CcSEcCtD
Clofazimine—Somnolence—Imiquimod—skin cancer	0.00101	0.00402	CcSEcCtD
Clofazimine—Photosensitivity reaction—Fluorouracil—skin cancer	0.001	0.00401	CcSEcCtD
Clofazimine—Decreased appetite—Imiquimod—skin cancer	0.000985	0.00394	CcSEcCtD
Clofazimine—Fatigue—Imiquimod—skin cancer	0.000977	0.0039	CcSEcCtD
Clofazimine—Hepatitis—Temozolomide—skin cancer	0.000956	0.00382	CcSEcCtD
Clofazimine—Asthenia—Vemurafenib—skin cancer	0.000954	0.00381	CcSEcCtD
Clofazimine—Pruritus—Vemurafenib—skin cancer	0.00094	0.00376	CcSEcCtD
Clofazimine—Visual impairment—Temozolomide—skin cancer	0.000921	0.00368	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000919	0.00367	CcSEcCtD
Clofazimine—Anaemia—Bleomycin—skin cancer	0.000912	0.00364	CcSEcCtD
Clofazimine—Diarrhoea—Vemurafenib—skin cancer	0.000909	0.00363	CcSEcCtD
Clofazimine—Body temperature increased—Imiquimod—skin cancer	0.000896	0.00358	CcSEcCtD
Clofazimine—Dizziness—Vemurafenib—skin cancer	0.000879	0.00351	CcSEcCtD
Clofazimine—Anaemia—Dactinomycin—skin cancer	0.00085	0.0034	CcSEcCtD
Clofazimine—Vomiting—Vemurafenib—skin cancer	0.000845	0.00338	CcSEcCtD
Clofazimine—Abdominal pain upper—Docetaxel—skin cancer	0.000839	0.00335	CcSEcCtD
Clofazimine—Rash—Vemurafenib—skin cancer	0.000838	0.00335	CcSEcCtD
Clofazimine—Dermatitis—Vemurafenib—skin cancer	0.000837	0.00334	CcSEcCtD
Clofazimine—Headache—Vemurafenib—skin cancer	0.000833	0.00333	CcSEcCtD
Clofazimine—Asthenia—Imiquimod—skin cancer	0.000813	0.00325	CcSEcCtD
Clofazimine—Oedema—Bleomycin—skin cancer	0.000805	0.00322	CcSEcCtD
Clofazimine—Pruritus—Imiquimod—skin cancer	0.000802	0.0032	CcSEcCtD
Clofazimine—Nausea—Vemurafenib—skin cancer	0.000789	0.00315	CcSEcCtD
Clofazimine—Diarrhoea—Imiquimod—skin cancer	0.000775	0.0031	CcSEcCtD
Clofazimine—Anaemia—Temozolomide—skin cancer	0.000769	0.00307	CcSEcCtD
Clofazimine—Anorexia—Bleomycin—skin cancer	0.000768	0.00307	CcSEcCtD
Clofazimine—Oedema—Dactinomycin—skin cancer	0.000751	0.003	CcSEcCtD
Clofazimine—Dizziness—Imiquimod—skin cancer	0.000749	0.00299	CcSEcCtD
Clofazimine—Vomiting—Imiquimod—skin cancer	0.000721	0.00288	CcSEcCtD
Clofazimine—Weight decreased—Docetaxel—skin cancer	0.000719	0.00287	CcSEcCtD
Clofazimine—Anorexia—Dactinomycin—skin cancer	0.000716	0.00286	CcSEcCtD
Clofazimine—Rash—Imiquimod—skin cancer	0.000715	0.00285	CcSEcCtD
Clofazimine—Dermatitis—Imiquimod—skin cancer	0.000714	0.00285	CcSEcCtD
Clofazimine—Headache—Imiquimod—skin cancer	0.00071	0.00284	CcSEcCtD
Clofazimine—Anaemia—Fluorouracil—skin cancer	0.000709	0.00283	CcSEcCtD
Clofazimine—Decreased appetite—Bleomycin—skin cancer	0.0007	0.0028	CcSEcCtD
Clofazimine—Jaundice—Docetaxel—skin cancer	0.00069	0.00276	CcSEcCtD
Clofazimine—Oedema—Temozolomide—skin cancer	0.000679	0.00271	CcSEcCtD
Clofazimine—Nausea—Imiquimod—skin cancer	0.000673	0.00269	CcSEcCtD
Clofazimine—Decreased appetite—Dactinomycin—skin cancer	0.000653	0.00261	CcSEcCtD
Clofazimine—Fatigue—Dactinomycin—skin cancer	0.000647	0.00259	CcSEcCtD
Clofazimine—Anorexia—Temozolomide—skin cancer	0.000647	0.00259	CcSEcCtD
Clofazimine—Body temperature increased—Bleomycin—skin cancer	0.000637	0.00254	CcSEcCtD
Clofazimine—Hepatitis—Docetaxel—skin cancer	0.000636	0.00254	CcSEcCtD
Clofazimine—Oedema—Fluorouracil—skin cancer	0.000626	0.0025	CcSEcCtD
Clofazimine—Visual impairment—Docetaxel—skin cancer	0.000613	0.00245	CcSEcCtD
Clofazimine—Somnolence—Temozolomide—skin cancer	0.000604	0.00241	CcSEcCtD
Clofazimine—Anorexia—Fluorouracil—skin cancer	0.000597	0.00238	CcSEcCtD
Clofazimine—Body temperature increased—Dactinomycin—skin cancer	0.000594	0.00237	CcSEcCtD
Clofazimine—Decreased appetite—Temozolomide—skin cancer	0.00059	0.00236	CcSEcCtD
Clofazimine—Fatigue—Temozolomide—skin cancer	0.000586	0.00234	CcSEcCtD
Clofazimine—Constipation—Temozolomide—skin cancer	0.000581	0.00232	CcSEcCtD
Clofazimine—Asthenia—Bleomycin—skin cancer	0.000578	0.00231	CcSEcCtD
Clofazimine—Pruritus—Bleomycin—skin cancer	0.00057	0.00228	CcSEcCtD
Clofazimine—Somnolence—Fluorouracil—skin cancer	0.000556	0.00222	CcSEcCtD
Clofazimine—Decreased appetite—Fluorouracil—skin cancer	0.000544	0.00217	CcSEcCtD
Clofazimine—Asthenia—Dactinomycin—skin cancer	0.000539	0.00215	CcSEcCtD
Clofazimine—Body temperature increased—Temozolomide—skin cancer	0.000537	0.00214	CcSEcCtD
Clofazimine—Diarrhoea—Dactinomycin—skin cancer	0.000514	0.00205	CcSEcCtD
Clofazimine—Vomiting—Bleomycin—skin cancer	0.000512	0.00204	CcSEcCtD
Clofazimine—Anaemia—Docetaxel—skin cancer	0.000512	0.00204	CcSEcCtD
Clofazimine—Rash—Bleomycin—skin cancer	0.000508	0.00203	CcSEcCtD
Clofazimine—Dermatitis—Bleomycin—skin cancer	0.000507	0.00203	CcSEcCtD
Clofazimine—Body temperature increased—Fluorouracil—skin cancer	0.000495	0.00198	CcSEcCtD
Clofazimine—Asthenia—Temozolomide—skin cancer	0.000487	0.00195	CcSEcCtD
Clofazimine—Pruritus—Temozolomide—skin cancer	0.000481	0.00192	CcSEcCtD
Clofazimine—Nausea—Bleomycin—skin cancer	0.000478	0.00191	CcSEcCtD
Clofazimine—Vomiting—Dactinomycin—skin cancer	0.000477	0.00191	CcSEcCtD
Clofazimine—Rash—Dactinomycin—skin cancer	0.000473	0.00189	CcSEcCtD
Clofazimine—Diarrhoea—Temozolomide—skin cancer	0.000465	0.00186	CcSEcCtD
Clofazimine—Oedema—Docetaxel—skin cancer	0.000452	0.0018	CcSEcCtD
Clofazimine—Dizziness—Temozolomide—skin cancer	0.000449	0.00179	CcSEcCtD
Clofazimine—Nausea—Dactinomycin—skin cancer	0.000446	0.00178	CcSEcCtD
Clofazimine—Pruritus—Fluorouracil—skin cancer	0.000443	0.00177	CcSEcCtD
Clofazimine—Vomiting—Temozolomide—skin cancer	0.000432	0.00172	CcSEcCtD
Clofazimine—Anorexia—Docetaxel—skin cancer	0.000431	0.00172	CcSEcCtD
Clofazimine—Rash—Temozolomide—skin cancer	0.000428	0.00171	CcSEcCtD
Clofazimine—Diarrhoea—Fluorouracil—skin cancer	0.000428	0.00171	CcSEcCtD
Clofazimine—Dermatitis—Temozolomide—skin cancer	0.000428	0.00171	CcSEcCtD
Clofazimine—Headache—Temozolomide—skin cancer	0.000426	0.0017	CcSEcCtD
Clofazimine—Dizziness—Fluorouracil—skin cancer	0.000414	0.00165	CcSEcCtD
Clofazimine—Nausea—Temozolomide—skin cancer	0.000403	0.00161	CcSEcCtD
Clofazimine—Somnolence—Docetaxel—skin cancer	0.000402	0.0016	CcSEcCtD
Clofazimine—Vomiting—Fluorouracil—skin cancer	0.000398	0.00159	CcSEcCtD
Clofazimine—Rash—Fluorouracil—skin cancer	0.000395	0.00158	CcSEcCtD
Clofazimine—Dermatitis—Fluorouracil—skin cancer	0.000394	0.00157	CcSEcCtD
Clofazimine—Decreased appetite—Docetaxel—skin cancer	0.000393	0.00157	CcSEcCtD
Clofazimine—Headache—Fluorouracil—skin cancer	0.000392	0.00157	CcSEcCtD
Clofazimine—Fatigue—Docetaxel—skin cancer	0.000389	0.00156	CcSEcCtD
Clofazimine—Constipation—Docetaxel—skin cancer	0.000386	0.00154	CcSEcCtD
Clofazimine—Nausea—Fluorouracil—skin cancer	0.000372	0.00148	CcSEcCtD
Clofazimine—Body temperature increased—Docetaxel—skin cancer	0.000357	0.00143	CcSEcCtD
Clofazimine—Asthenia—Docetaxel—skin cancer	0.000324	0.00129	CcSEcCtD
Clofazimine—Pruritus—Docetaxel—skin cancer	0.00032	0.00128	CcSEcCtD
Clofazimine—Diarrhoea—Docetaxel—skin cancer	0.000309	0.00123	CcSEcCtD
Clofazimine—Dizziness—Docetaxel—skin cancer	0.000299	0.00119	CcSEcCtD
Clofazimine—Vomiting—Docetaxel—skin cancer	0.000287	0.00115	CcSEcCtD
Clofazimine—Rash—Docetaxel—skin cancer	0.000285	0.00114	CcSEcCtD
Clofazimine—Dermatitis—Docetaxel—skin cancer	0.000285	0.00114	CcSEcCtD
Clofazimine—Headache—Docetaxel—skin cancer	0.000283	0.00113	CcSEcCtD
Clofazimine—Nausea—Docetaxel—skin cancer	0.000268	0.00107	CcSEcCtD
